This study is in progress, not accepting new patients
Atacicept in Subjects With IgA Nephropathy
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
- Principal Investigator
- by Anjay Rastogi, MD, PhD (ucla)

Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientist at University of California Health
- Anjay Rastogi, MD, PhD (ucla)
Professor of Clinical, Medicine. Authored (or co-authored) 90 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Vera Therapeutics, Inc.
- Links
- Vera Therapeutics, Inc Company Website ORIGIN 3 Study Website
- ID
- NCT04716231
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 376 study participants
- Last Updated